Supplements
curcumin is safe at typical supplement doses
In plain terms: Is it safe to take turmeric or curcumin supplements?
Part of: 🧪 turmeric & curcumin
Usually, but not risk-free. It's well-tolerated in trials, yet there's a real and growing cluster of liver-injury cases from concentrated supplements — some serious — plus it can reduce iron absorption and amplify blood thinners. Cooking with turmeric is fine; high-dose capsules deserve caution.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Mostly, but not risk-free — which is why this is contested, not a clean yes. Curcumin is well-tolerated in controlled trials, yet real-world pharmacovigilance has logged a growing cluster of idiosyncratic liver-injury cases (the US DILIN series; turmeric now ranks among the more common supplement causes of hepatotoxicity), some severe and HLA-linked and often tied to high-dose…
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Gupta 2013 · AAPS J | observational | supports | low | Clinical-trials review: curcumin was generally safe and well-tolerated across trials. |
| Sohal 2021 · Int Med Case Rep J | observational | contradicts | low | Case reports: turmeric-induced hepatotoxicity that resolved on discontinuation. |
| Hsu 2007 · Adv Exp Med Biol | observational | supports | low | Phase I studies: curcumin was well-tolerated even at high oral doses. |
| Chen D et al 2025 · study_type: meta-analysis | meta-analysis | supports | moderate | Network meta-analysis of 21 RCTs (n=1,463) of dietary supplements (including curcumin) for plaque psoriasis; adverse events were comparable across interventions (risk ratio 1.02, 95% CI 0.94-1.10), with no supplement showing excess harm. |
| Wanta A et al 2025 · study_type: animal | animal | supports | low | OECD TG 420 acute oral toxicity study of a curcumin-ascorbic acid-polysaccharide-β-cyclodextrin complex in 7 female mice at 300/2000 mg/kg; LD50 >2000 mg/kg, no signs of toxicity or organ (incl. liver) abnormalities at 24h/48h/14 days. |
| Storka 2015 · Int J Clin Pharmacol Ther | RCT | supports | moderate | Phase I trial: liposomal curcumin was safe and well-tolerated in healthy humans with a favorable PK profile. |
| Halegoua-DeMarzio 2023 · Am J Med | observational | contradicts | moderate | US DILIN case series: 10 cases of turmeric-associated liver injury, some severe and HLA-B35:01-linked — a real idiosyncratic hepatotoxicity signal. |
| Likhitsup 2024 · JAMA Netw Open | observational | contradicts | low | JAMA Network Open: turmeric/curcumin is among the most-used potentially hepatotoxic botanicals, with substantial US population exposure. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.